Evidence map›Paper›PMID 38023724›Full record

ArticleBioengineering & translational medicine2023

Drug cross-linking electrospun fiber for effective infected wound healing.

Yuting Luo, Sen Zheng, Kun Wang, Hangqi Luo, Huiling Shi, Yanna Cui, Bingxin Li, Huacheng He, Jiang Wu

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Bioengineering & translational medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Yuting LuoSchool of Pharmaceutical Sciences, Key Laboratory of Biotechnology and Pharmaceutical Engineering Wenzhou Medical University Wenzhou Zhejiang People's Republic of China.
Sen ZhengSchool of Pharmaceutical Sciences, Key Laboratory of Biotechnology and Pharmaceutical Engineering Wenzhou Medical University Wenzhou Zhejiang People's Republic of China.
Kun WangSchool of Pharmaceutical Sciences, Key Laboratory of Biotechnology and Pharmaceutical Engineering Wenzhou Medical University Wenzhou Zhejiang People's Republic of China.ORCID https://orcid.org/0000-0001-9636-9264
Hangqi LuoSchool of Pharmaceutical Sciences, Key Laboratory of Biotechnology and Pharmaceutical Engineering Wenzhou Medical University Wenzhou Zhejiang People's Republic of China.
Huiling ShiSchool of Pharmaceutical Sciences, Key Laboratory of Biotechnology and Pharmaceutical Engineering Wenzhou Medical University Wenzhou Zhejiang People's Republic of China.
Yanna CuiSchool of Pharmaceutical Sciences, Key Laboratory of Biotechnology and Pharmaceutical Engineering Wenzhou Medical University Wenzhou Zhejiang People's Republic of China.
Bingxin LiCollege of Chemistry and Materials Engineering Wenzhou University Wenzhou Zhejiang People's Republic of China.
Huacheng HeCollege of Chemistry and Materials Engineering Wenzhou University Wenzhou Zhejiang People's Republic of China.ORCID https://orcid.org/0000-0001-5177-0636
Jiang WuSchool of Pharmaceutical Sciences, Key Laboratory of Biotechnology and Pharmaceutical Engineering Wenzhou Medical University Wenzhou Zhejiang People's Republic of China.ORCID https://orcid.org/0000-0003-1929-3328
Wenzhou Medical University · CNWenzhou University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The management of infected wounds is still an intractable challenge in clinic. Development of antibacterial wound dressing is of great practical significance for wound management. Herein, a natural-derived antibacterial drug, tannic acid (TA), was incorporated into the electrospun polyvinyl alcohol (PVA) fiber (TA/PVA fiber, 952 ± 40 nm in diameter). TA worked as a cross-linker via hydrogen bonding with PVA to improve the physicochemical properties of the fiber and to reach a sustained drug release (88% release of drug at 48 h). Improved mechanical property (0.8-1.2 MPa) and computational simulation validated the formation of the hydrogen bonds between TA and PVA. Moreover, the antibacterial and anti-inflammatory characteristics of TA laid the foundation for the application of TA/PVA fiber in repairing infected wounds. Meanwhile, in vitro studies proved the high hemocompatibility and cytocompatibility of TA/PVA fiber. Further in vivo animal investigation showed that the TA/PVA fiber promoted the repair of infected wound by inhibiting the bacterial growth, promoting granulation formation, and collagen matrix deposition, accelerating angiogenesis, and inducing M2 macrophage polarization within 14 days. All the data demonstrated that the TA cross-linked fiber would be a potent dressing for bacteria-infected wound healing.

Indexed as

electrospinninginfected woundmolecular simulationpolyvinyl alcoholtannic acid

Identifiers

PMID38023724
PMCPMC10658581
OpenAlexW4379506033

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.